Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	oxidoreductase activity	NQO2 POR CYP27C1 CYP21A2 BCO1 DNAJC10	1.03e-04	766	21	6	GO:0016491
GeneOntologyMolecularFunction	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	BIRC2 BIRC3	2.87e-04	24	21	2	GO:0043027
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	POR CYP27C1 CYP21A2	1.06e-03	194	21	3	GO:0016705
GeneOntologyMolecularFunction	cysteine-type endopeptidase regulator activity involved in apoptotic process	BIRC2 BIRC3	1.46e-03	54	21	2	GO:0043028
GeneOntologyMolecularFunction	flavin adenine dinucleotide binding	NQO2 POR	4.34e-03	94	21	2	GO:0050660
GeneOntologyMolecularFunction	oxidoreductase activity, acting on NAD(P)H	NQO2 POR	4.43e-03	95	21	2	GO:0016651
GeneOntologyMolecularFunction	dioxygenase activity	POR BCO1	4.71e-03	98	21	2	GO:0051213
GeneOntologyMolecularFunction	monooxygenase activity	CYP27C1 CYP21A2	6.43e-03	115	21	2	GO:0004497
GeneOntologyMolecularFunction	ubiquitin protein ligase activity	BIRC2 BIRC3 TRIM48	6.65e-03	372	21	3	GO:0061630
GeneOntologyMolecularFunction	transition metal ion binding	NQO2 BIRC2 CYP27C1 CYP21A2 TRIM48	6.78e-03	1189	21	5	GO:0046914
GeneOntologyMolecularFunction	electron transfer activity	NQO2 POR	7.44e-03	124	21	2	GO:0009055
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	BIRC2 BIRC3 TRIM48	8.01e-03	398	21	3	GO:0061659
GeneOntologyMolecularFunction	heme binding	CYP27C1 CYP21A2	1.13e-02	154	21	2	GO:0020037
GeneOntologyMolecularFunction	carboxylic ester hydrolase activity	NDST3 ABHD16A	1.17e-02	157	21	2	GO:0052689
GeneOntologyMolecularFunction	protein-folding chaperone binding	BIRC2 DNAJC10	1.23e-02	161	21	2	GO:0051087
GeneOntologyMolecularFunction	tetrapyrrole binding	CYP27C1 CYP21A2	1.27e-02	164	21	2	GO:0046906
GeneOntologyMolecularFunction	ubiquitin-protein transferase activity	BIRC2 BIRC3 TRIM48	1.28e-02	473	21	3	GO:0004842
GeneOntologyMolecularFunction	iron ion binding	CYP27C1 CYP21A2	1.30e-02	166	21	2	GO:0005506
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	BIRC2 BIRC3 TRIM48	1.58e-02	512	21	3	GO:0019787
GeneOntologyMolecularFunction	extracellular matrix structural constituent	MUC5AC TINAG	1.65e-02	188	21	2	GO:0005201
GeneOntologyMolecularFunction	aminoacyltransferase activity	BIRC2 BIRC3 TRIM48	1.75e-02	532	21	3	GO:0016755
GeneOntologyBiologicalProcess	regulation of hormone levels	POR CYP27C1 CHD7 CYP21A2 GALR1 BCO1	4.61e-05	684	21	6	GO:0010817
GeneOntologyBiologicalProcess	regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	BIRC2 BIRC3	1.17e-04	16	21	2	GO:0070424
GeneOntologyBiologicalProcess	hormone metabolic process	POR CYP27C1 CYP21A2 BCO1	1.80e-04	286	21	4	GO:0042445
GeneOntologyBiologicalProcess	positive regulation of protein polyubiquitination	BIRC2 BIRC3	1.86e-04	20	21	2	GO:1902916
GeneOntologyBiologicalProcess	regulation of RIG-I signaling pathway	BIRC2 BIRC3	2.05e-04	21	21	2	GO:0039535
GeneOntologyBiologicalProcess	retinal metabolic process	CYP27C1 BCO1	2.05e-04	21	21	2	GO:0042574
GeneOntologyBiologicalProcess	negative regulation of necroptotic process	BIRC2 BIRC3	2.69e-04	24	21	2	GO:0060546
GeneOntologyBiologicalProcess	negative regulation of programmed necrotic cell death	BIRC2 BIRC3	3.16e-04	26	21	2	GO:0062099
GeneOntologyBiologicalProcess	RIG-I signaling pathway	BIRC2 BIRC3	4.22e-04	30	21	2	GO:0039529
GeneOntologyBiologicalProcess	nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway	BIRC2 BIRC3	4.22e-04	30	21	2	GO:0035872
GeneOntologyBiologicalProcess	regulation of protein polyubiquitination	BIRC2 BIRC3	4.81e-04	32	21	2	GO:1902914
GeneOntologyBiologicalProcess	regulation of necroptotic process	BIRC2 BIRC3	6.44e-04	37	21	2	GO:0060544
GeneOntologyBiologicalProcess	regulation of toll-like receptor signaling pathway	BIRC2 BIRC3	7.52e-04	40	21	2	GO:0034121
GeneOntologyBiologicalProcess	olefinic compound metabolic process	CYP27C1 CYP21A2 BCO1	7.74e-04	180	21	3	GO:0120254
GeneOntologyBiologicalProcess	regulation of programmed necrotic cell death	BIRC2 BIRC3	8.69e-04	43	21	2	GO:0062098
GeneOntologyBiologicalProcess	regulation of reactive oxygen species metabolic process	NQO2 BIRC2 BIRC3	8.78e-04	188	21	3	GO:2000377
GeneOntologyBiologicalProcess	necroptotic process	BIRC2 BIRC3	1.32e-03	53	21	2	GO:0070266
GeneOntologyBiologicalProcess	retinol metabolic process	CYP27C1 BCO1	1.32e-03	53	21	2	GO:0042572
MousePheno	aorta coarctation	CHD7 BRD2	1.08e-04	13	17	2	MP:0003387
MousePheno	abnormal common carotid artery morphology	CHD7 BRD2	1.08e-04	13	17	2	MP:0012729
MousePheno	interrupted aortic arch, type b	CHD7 BRD2	1.65e-04	16	17	2	MP:0011659
MousePheno	abnormal middle ear morphology	MUC5B CHD7 BRD2	1.75e-04	92	17	3	MP:0000049
MousePheno	abnormal epithalamus morphology	CHD7 BRD2	2.35e-04	19	17	2	MP:0000840
MousePheno	increased circulating glucagon level	G6PC3 BRD2	2.61e-04	20	17	2	MP:0002712
MousePheno	abnormal circulating cholesterol level	G6PC3 NDST3 POR CHD7 BRD2 BCO1	2.89e-04	823	17	6	MP:0000180
MousePheno	decreased magnesium level	ABHD16A CHD7	3.17e-04	22	17	2	MP:0031658
MousePheno	decreased circulating magnesium level	ABHD16A CHD7	3.17e-04	22	17	2	MP:0010093
MousePheno	abnormal cholesterol level	G6PC3 NDST3 POR CHD7 BRD2 BCO1	3.83e-04	867	17	6	MP:0003947
MousePheno	abnormal sterol level	G6PC3 NDST3 POR CHD7 BRD2 BCO1	4.15e-04	880	17	6	MP:0012224
MousePheno	abnormal cardiac outflow tract development	POR CHD7 BRD2	5.31e-04	134	17	3	MP:0006126
MousePheno	abnormal vagus nerve morphology	CHD7 BRD2	5.54e-04	29	17	2	MP:0001074
MousePheno	abnormal secretory circumventricular organ morphology	CHD7 BRD2	5.54e-04	29	17	2	MP:0013563
MousePheno	abnormal cholesterol homeostasis	G6PC3 NDST3 POR CHD7 BRD2 BCO1	5.78e-04	936	17	6	MP:0005278
MousePheno	decreased leukocyte cell number	G6PC3 NDST3 BIRC2 BIRC3 CHD7 GALR1 BRD2	6.05e-04	1342	17	7	MP:0000221
MousePheno	increased susceptibility to otitis media	MUC5B CHD7	6.34e-04	31	17	2	MP:0001850
MousePheno	abnormal circumventricular organ morphology	CHD7 BRD2	6.34e-04	31	17	2	MP:0013562
MousePheno	ear inflammation	MUC5B CHD7	1.06e-03	40	17	2	MP:0001849
MousePheno	abnormal circulating glucagon level	G6PC3 BRD2	1.06e-03	40	17	2	MP:0002695
MousePheno	abnormal lymphocyte morphology	NQO2 NDST3 BIRC2 BIRC3 CHD7 GALR1 BRD2	1.11e-03	1483	17	7	MP:0002619
MousePheno	interrupted aortic arch	CHD7 BRD2	1.11e-03	41	17	2	MP:0004157
MousePheno	decreased circulating cholesterol level	G6PC3 NDST3 POR CHD7	1.14e-03	397	17	4	MP:0005179
MousePheno	interrupted aorta	CHD7 BRD2	1.22e-03	43	17	2	MP:0010544
MousePheno	abnormal carotid artery morphology	CHD7 BRD2	1.28e-03	44	17	2	MP:0004181
MousePheno	abnormal myocardium layer morphology	POR FHOD3 CHD7 BRD2	1.33e-03	414	17	4	MP:0005329
MousePheno	decreased cholesterol level	G6PC3 NDST3 POR CHD7	1.38e-03	418	17	4	MP:0003983
MousePheno	decreased sterol level	G6PC3 NDST3 POR CHD7	1.41e-03	421	17	4	MP:0012225
MousePheno	abnormal heart layer morphology	POR FHOD3 CHD7 BRD2	1.43e-03	422	17	4	MP:0010545
MousePheno	abnormal magnesium level	ABHD16A CHD7	1.58e-03	49	17	2	MP:0020883
MousePheno	abnormal circulating magnesium level	ABHD16A CHD7	1.58e-03	49	17	2	MP:0001771
MousePheno	abnormal magnesium ion homeostasis	ABHD16A CHD7	1.65e-03	50	17	2	MP:0011979
MousePheno	abnormal immune serum protein physiology	BIRC2 MUC5AC BIRC3 ABHD16A MUC5B BRD2	1.83e-03	1165	17	6	MP:0002723
MousePheno	abnormal middle ear ossicle morphology	CHD7 BRD2	2.06e-03	56	17	2	MP:0005105
MousePheno	abnormal subclavian artery morphology	CHD7 BRD2	2.06e-03	56	17	2	MP:0003395
MousePheno	decreased body length	G6PC3 ABHD16A CHD7 DNAJC10	2.36e-03	484	17	4	MP:0001258
MousePheno	abnormal fluid regulation	POR FHOD3 MUC5B CHD7 BRD2	2.42e-03	826	17	5	MP:0001784
MousePheno	abnormal cardiac muscle tissue morphology	POR FHOD3 CHD7 BRD2	2.45e-03	489	17	4	MP:0010630
MousePheno	hepatic steatosis	POR BRD2 BCO1	2.58e-03	232	17	3	MP:0002628
Domain	WxxW_domain	MUC5AC MUC5B	1.80e-05	6	21	2	IPR025155
Domain	Mucin2_WxxW	MUC5AC MUC5B	1.80e-05	6	21	2	PF13330
Domain	BIR	BIRC2 BIRC3	3.36e-05	8	21	2	SM00238
Domain	BIR_REPEAT_2	BIRC2 BIRC3	3.36e-05	8	21	2	PS50143
Domain	-	BIRC2 BIRC3	3.36e-05	8	21	2	1.10.1170.10
Domain	BIR_rpt	BIRC2 BIRC3	3.36e-05	8	21	2	IPR001370
Domain	BIR_REPEAT_1	BIRC2 BIRC3	3.36e-05	8	21	2	PS01282
Domain	BIR	BIRC2 BIRC3	3.36e-05	8	21	2	PF00653
Domain	Flavoprotein-like_dom	NQO2 POR	5.39e-05	10	21	2	IPR029039
Domain	-	NQO2 POR	5.39e-05	10	21	2	3.40.50.360
Domain	TIL	MUC5AC MUC5B	7.89e-05	12	21	2	PF01826
Domain	C8	MUC5AC MUC5B	7.89e-05	12	21	2	PF08742
Domain	Unchr_dom_Cys-rich	MUC5AC MUC5B	9.32e-05	13	21	2	IPR014853
Domain	C8	MUC5AC MUC5B	9.32e-05	13	21	2	SM00832
Domain	TIL_dom	MUC5AC MUC5B	1.09e-04	14	21	2	IPR002919
Domain	Glyco_hormone_CN	MUC5AC MUC5B	1.25e-04	15	21	2	IPR006208
Domain	Cys_knot	MUC5AC MUC5B	1.25e-04	15	21	2	PF00007
Domain	CARD	BIRC2 BIRC3	1.43e-04	16	21	2	SM00114
Domain	VWFD	MUC5AC MUC5B	1.43e-04	16	21	2	PS51233
Domain	VWD	MUC5AC MUC5B	1.43e-04	16	21	2	SM00216
Domain	VWF_type-D	MUC5AC MUC5B	1.43e-04	16	21	2	IPR001846
Domain	VWD	MUC5AC MUC5B	1.43e-04	16	21	2	PF00094
Domain	CTCK_1	MUC5AC MUC5B	1.82e-04	18	21	2	PS01185
Domain	VWC_out	MUC5AC MUC5B	2.04e-04	19	21	2	SM00215
Domain	CT	MUC5AC MUC5B	2.74e-04	22	21	2	SM00041
Domain	Cys_knot_C	MUC5AC MUC5B	3.56e-04	25	21	2	IPR006207
Domain	CTCK_2	MUC5AC MUC5B	3.56e-04	25	21	2	PS01225
Domain	CARD	BIRC2 BIRC3	4.47e-04	28	21	2	PF00619
Domain	VWC	MUC5AC MUC5B	4.47e-04	28	21	2	PF00093
Domain	CARD	BIRC2 BIRC3	5.49e-04	31	21	2	IPR001315
Domain	CARD	BIRC2 BIRC3	6.23e-04	33	21	2	PS50209
Domain	VWFC_1	MUC5AC MUC5B	7.41e-04	36	21	2	PS01208
Domain	VWC	MUC5AC MUC5B	8.26e-04	38	21	2	SM00214
Domain	VWFC_2	MUC5AC MUC5B	8.26e-04	38	21	2	PS50184
Domain	VWF_dom	MUC5AC MUC5B	1.01e-03	42	21	2	IPR001007
Domain	Cyt_P450_E_grp-I	CYP27C1 CYP21A2	1.16e-03	45	21	2	IPR002401
Domain	Cyt_P450_CS	CYP27C1 CYP21A2	1.60e-03	53	21	2	IPR017972
Domain	CYTOCHROME_P450	CYP27C1 CYP21A2	1.85e-03	57	21	2	PS00086
Domain	-	CYP27C1 CYP21A2	1.92e-03	58	21	2	1.10.630.10
Domain	p450	CYP27C1 CYP21A2	1.92e-03	58	21	2	PF00067
Domain	Cyt_P450	CYP27C1 CYP21A2	2.05e-03	60	21	2	IPR001128
Domain	ZF_RING_1	BIRC2 BIRC3 TRIM48	4.04e-03	291	21	3	PS00518
Domain	ZF_RING_2	BIRC2 BIRC3 TRIM48	4.32e-03	298	21	3	PS50089
Domain	RING	BIRC2 BIRC3 TRIM48	4.61e-03	305	21	3	SM00184
Domain	-	BIRC2 BIRC3	4.84e-03	93	21	2	1.10.533.10
Domain	DEATH-like_dom	BIRC2 BIRC3	5.47e-03	99	21	2	IPR011029
Domain	Znf_RING	BIRC2 BIRC3 TRIM48	5.55e-03	326	21	3	IPR001841
Domain	-	NDST3 N4BP2L2 EEF2 CHD7	8.78e-03	746	21	4	3.40.50.300
Pathway	KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY	BIRC2 BIRC3	8.97e-05	12	17	2	M47600
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC5AC MUC5B	1.63e-04	16	17	2	M27410
Pathway	WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM	POR CYP21A2	1.63e-04	16	17	2	M39815
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC5AC MUC5B	1.84e-04	17	17	2	M27412
Pathway	REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY	BIRC2 BIRC3	1.84e-04	17	17	2	M27561
Pathway	REACTOME_DISEASES_OF_METABOLISM	G6PC3 MUC5AC MUC5B CYP21A2	1.92e-04	250	17	4	M27554
Pathway	REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY	BIRC2 BIRC3	2.07e-04	18	17	2	MM15275
Pathway	SA_CASPASE_CASCADE	BIRC2 BIRC3	2.31e-04	19	17	2	M7997
Pathway	REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT	BIRC2 BIRC3	2.31e-04	19	17	2	M27020
Pathway	BIOCARTA_MITOCHONDRIA_PATHWAY	BIRC2 BIRC3	2.31e-04	19	17	2	M16257
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	NQO2 POR CYP21A2	2.46e-04	104	17	3	M738
Pathway	BIOCARTA_MITOCHONDRIA_PATHWAY	BIRC2 BIRC3	2.84e-04	21	17	2	MM1484
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5AC MUC5B	2.84e-04	21	17	2	MM15706
Pathway	BIOCARTA_CASPASE_PATHWAY	BIRC2 BIRC3	3.12e-04	22	17	2	M17902
Pathway	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1	BIRC2 BIRC3	3.41e-04	23	17	2	M1003
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5AC MUC5B	3.41e-04	23	17	2	M556
Pathway	REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING	BIRC2 BIRC3	3.41e-04	23	17	2	MM15177
Pathway	BIOCARTA_CASPASE_PATHWAY	BIRC2 BIRC3	4.04e-04	25	17	2	MM1359
Pathway	REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING	BIRC2 BIRC3	4.04e-04	25	17	2	M27435
Pathway	REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1	BIRC2 BIRC3	4.04e-04	25	17	2	MM15646
Pathway	REACTOME_DECTIN_2_FAMILY	MUC5AC MUC5B	4.37e-04	26	17	2	M27483
Pathway	BIOCARTA_DEATH_PATHWAY	BIRC2 BIRC3	5.45e-04	29	17	2	M14971
Pathway	PID_CD40_PATHWAY	BIRC2 BIRC3	6.24e-04	31	17	2	M45
Pathway	REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS	BIRC2 BIRC3	6.65e-04	32	17	2	M29666
Pathway	REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY	BIRC2 BIRC3	7.07e-04	33	17	2	M27438
Pathway	REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY	BIRC2 BIRC3	7.07e-04	33	17	2	MM15180
Pathway	REACTOME_NOD1_2_SIGNALING_PATHWAY	BIRC2 BIRC3	7.07e-04	33	17	2	MM14663
Pathway	WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING	BIRC2 BIRC3	7.96e-04	35	17	2	M39529
Pathway	REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS	BIRC2 BIRC3	7.96e-04	35	17	2	MM15168
Pathway	REACTOME_NOD1_2_SIGNALING_PATHWAY	BIRC2 BIRC3	8.42e-04	36	17	2	M1059
Pathway	PID_FAS_PATHWAY	BIRC2 BIRC3	9.38e-04	38	17	2	M94
Pathway	WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING	BIRC2 BIRC3	1.15e-03	42	17	2	M39452
Pathway	WP_OXIDATION_BY_CYTOCHROME_P450	POR CYP21A2	1.20e-03	43	17	2	MM15873
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II	NDST3 CYP27C1 CYP21A2	1.28e-03	183	17	3	M39588
Pathway	PID_TNF_PATHWAY	BIRC2 BIRC3	1.37e-03	46	17	2	M128
Pathway	REACTOME_REGULATION_OF_TNFR1_SIGNALING	BIRC2 BIRC3	1.43e-03	47	17	2	MM15179
Pathway	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	BIRC2 BIRC3	1.43e-03	47	17	2	MM14664
Pathway	PID_CASPASE_PATHWAY	BIRC2 BIRC3	1.69e-03	51	17	2	M220
Pathway	REACTOME_TNF_SIGNALING	BIRC2 BIRC3	2.03e-03	56	17	2	MM15453
Pathway	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	BIRC2 BIRC3	2.03e-03	56	17	2	M1074
Pathway	BIOCARTA_HIVNEF_PATHWAY	BIRC2 BIRC3	2.03e-03	56	17	2	M13968
Pathway	REACTOME_TNF_SIGNALING	BIRC2 BIRC3	2.10e-03	57	17	2	M27713
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	NQO2 POR CYP21A2	2.17e-03	220	17	3	M10320
Pathway	REACTOME_REGULATED_NECROSIS	BIRC2 BIRC3	2.25e-03	59	17	2	M41803
Pathway	REACTOME_REGULATED_NECROSIS	BIRC2 BIRC3	2.25e-03	59	17	2	MM15169
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC5AC MUC5B	2.33e-03	60	17	2	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC5AC MUC5B	2.48e-03	62	17	2	M546
Pathway	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	BIRC2 BIRC3	2.48e-03	62	17	2	M15569
Pathway	WP_OXIDATION_BY_CYTOCHROME_P450	POR CYP27C1	2.48e-03	62	17	2	M39653
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	POR CYP21A2	2.64e-03	64	17	2	M5650
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC5AC MUC5B	2.98e-03	68	17	2	M27303
Pathway	PID_P75_NTR_PATHWAY	BIRC2 BIRC3	2.98e-03	68	17	2	M153
Pathway	WP_GLUCOCORTICOID_RECEPTOR_PATHWAY	BIRC2 BIRC3	3.15e-03	70	17	2	M40042
Pathway	WP_IL18_SIGNALING	BIRC3 ABHD16A EEF2	3.99e-03	273	17	3	M39818
Pathway	WP_APOPTOSIS	BIRC2 BIRC3	4.40e-03	83	17	2	MM15972
Pathway	KEGG_SMALL_CELL_LUNG_CANCER	BIRC2 BIRC3	4.50e-03	84	17	2	M3228
Pathway	KEGG_APOPTOSIS	BIRC2 BIRC3	4.82e-03	87	17	2	M8492
Pathway	WP_APOPTOSIS	BIRC2 BIRC3	4.93e-03	88	17	2	M39654
Pathway	WP_TNFALPHA_SIGNALING	BIRC2 BIRC3	5.38e-03	92	17	2	M39662
Pathway	WP_APOPTOSIS_MODULATION_AND_SIGNALING	BIRC2 BIRC3	5.38e-03	92	17	2	M39664
Pathway	WP_SMALL_CELL_LUNG_CANCER	BIRC2 BIRC3	5.84e-03	96	17	2	M39834
Pathway	REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY	BIRC2 BIRC3	5.96e-03	97	17	2	MM15268
Pathway	REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY	BIRC2 BIRC3	6.44e-03	101	17	2	M27552
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	NQO2 CYP21A2	6.95e-03	105	17	2	MM14842
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC5AC MUC5B	7.47e-03	109	17	2	MM15164
Pathway	REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE	BIRC2 BIRC3	7.47e-03	109	17	2	M29565
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC5AC MUC5B	7.74e-03	111	17	2	M27416
Pathway	WP_GASTRIN_SIGNALING	BIRC2 BIRC3	8.28e-03	115	17	2	M39866
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	BIRC2 MUC5AC BIRC3 MUC5B EEF2	8.91e-03	1128	17	5	M1036
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	BIRC2 BIRC3	9.28e-03	122	17	2	MM14640
Pathway	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	BIRC2 BIRC3	1.13e-02	135	17	2	M15247
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC5AC MUC5B	1.21e-02	140	17	2	M27484
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	BIRC2 BIRC3	1.24e-02	142	17	2	MM15431
Pathway	REACTOME_PROGRAMMED_CELL_DEATH	BIRC2 BIRC3	1.24e-02	142	17	2	MM15178
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC5AC MUC5B	1.26e-02	143	17	2	M27275
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION	NDST3 CYP21A2	1.43e-02	153	17	2	MM15844
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	BIRC2 BIRC3	1.45e-02	154	17	2	M27697
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_CASCADES	BIRC2 BIRC3	1.47e-02	155	17	2	MM14665
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_CASCADES	BIRC2 BIRC3	1.75e-02	170	17	2	M7494
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5AC MUC5B	3.47e-07	2	21	2	7513696
Pubmed	Mucin deficiency causes functional and structural changes of the ocular surface.	MUC5AC MUC5B	3.47e-07	2	21	2	23272068
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5AC MUC5B	3.47e-07	2	21	2	31030254
Pubmed	c-IAP1 and c-IAP2 redundancy differs between T and B cells.	BIRC2 BIRC3	3.47e-07	2	21	2	23799077
Pubmed	Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.	BIRC2 BIRC3	3.47e-07	2	21	2	31126323
Pubmed	Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.	MUC5AC MUC5B	3.47e-07	2	21	2	27729120
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5AC MUC5B	3.47e-07	2	21	2	34058148
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5AC MUC5B	3.47e-07	2	21	2	37146737
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5AC MUC5B	3.47e-07	2	21	2	23527003
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5AC MUC5B	3.47e-07	2	21	2	14988081
Pubmed	Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are increased after labour in foetal membranes and myometrium and are essential for TNF-α-induced expression of pro-labour mediators.	BIRC2 BIRC3	3.47e-07	2	21	2	25046208
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5AC MUC5B	3.47e-07	2	21	2	16540890
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5AC MUC5B	3.47e-07	2	21	2	15563276
Pubmed	De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.	MUC5AC MUC5B	3.47e-07	2	21	2	36111525
Pubmed	Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells.	BIRC2 BIRC3	3.47e-07	2	21	2	23250032
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5AC MUC5B	3.47e-07	2	21	2	17621824
Pubmed	Muc5b is required for airway defence.	MUC5AC MUC5B	3.47e-07	2	21	2	24317696
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5AC MUC5B	3.47e-07	2	21	2	27845589
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5AC MUC5B	3.47e-07	2	21	2	22391959
Pubmed	C-Mannosylation of MUC5AC and MUC5B Cys subdomains.	MUC5AC MUC5B	3.47e-07	2	21	2	14718370
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5AC MUC5B	3.47e-07	2	21	2	35776514
Pubmed	The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.	POR CYP21A2	3.47e-07	2	21	2	18397975
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5AC MUC5B	3.47e-07	2	21	2	27435107
Pubmed	A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.	BIRC2 BIRC3	3.47e-07	2	21	2	12651874
Pubmed	Self-termination of the terminator.	BIRC2 BIRC3	3.47e-07	2	21	2	19008929
Pubmed	Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors.	BIRC2 BIRC3	3.47e-07	2	21	2	22434933
Pubmed	IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.	BIRC2 BIRC3	3.47e-07	2	21	2	20651737
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5AC MUC5B	3.47e-07	2	21	2	24327612
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5AC MUC5B	3.47e-07	2	21	2	26871672
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5AC MUC5B	3.47e-07	2	21	2	21653907
Pubmed	Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli.	BIRC2 BIRC3	3.47e-07	2	21	2	10797013
Pubmed	MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.	MUC5AC MUC5B	3.47e-07	2	21	2	36427316
Pubmed	Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients.	BIRC2 BIRC3	3.47e-07	2	21	2	21795072
Pubmed	Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis.	BIRC2 BIRC3	3.47e-07	2	21	2	14708638
Pubmed	BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.	BIRC2 BIRC3	3.47e-07	2	21	2	34997070
Pubmed	Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin.	MUC5AC MUC5B	3.47e-07	2	21	2	32348677
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5AC MUC5B	3.47e-07	2	21	2	11587997
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5AC MUC5B	3.47e-07	2	21	2	28607090
Pubmed	Prognostic Significance of the BIRC2-BIRC3 Gene Signature in Head and Neck Squamous Cell Carcinoma.	BIRC2 BIRC3	3.47e-07	2	21	2	35985688
Pubmed	Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2.	BIRC2 BIRC3	3.47e-07	2	21	2	9892732
Pubmed	Functional evaluation of the role of inhibitor of apoptosis proteins in chronic lymphocytic leukemia.	BIRC2 BIRC3	3.47e-07	2	21	2	15183896
Pubmed	Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.	BIRC2 BIRC3	3.47e-07	2	21	2	29452637
Pubmed	Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate.	BIRC2 BIRC3	3.47e-07	2	21	2	20078866
Pubmed	Cellular inhibitors of apoptosis (cIAP) 1 and 2 are increased in placenta from obese pregnant women.	BIRC2 BIRC3	3.47e-07	2	21	2	25113061
Pubmed	Degradation of cIAPs contributes to hepatocyte lipoapoptosis.	BIRC2 BIRC3	3.47e-07	2	21	2	24008361
Pubmed	Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.	MUC5AC MUC5B	3.47e-07	2	21	2	24332705
Pubmed	Genomic characterization of the mouse inhibitor of apoptosis protein 1 and 2 genes.	BIRC2 BIRC3	3.47e-07	2	21	2	9441758
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5AC MUC5B	3.47e-07	2	21	2	34656442
Pubmed	Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.	BIRC2 BIRC3	1.04e-06	3	21	2	29518103
Pubmed	The ubiquitin-associated domain of cellular inhibitor of apoptosis proteins facilitates ubiquitylation.	BIRC2 BIRC3	1.04e-06	3	21	2	25065467
Pubmed	Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment.	BIRC2 BIRC3	1.04e-06	3	21	2	18784070
Pubmed	Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells.	MUC5AC MUC5B	1.04e-06	3	21	2	27776277
Pubmed	Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.	BIRC2 BIRC3	1.04e-06	3	21	2	12243753
Pubmed	To fight or die - inhibitor of apoptosis proteins at the crossroad of innate immunity and death.	BIRC2 BIRC3	1.04e-06	3	21	2	20888210
Pubmed	Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.	BIRC2 BIRC3	1.04e-06	3	21	2	21393245
Pubmed	Autophagy of mucin granules contributes to resolution of airway mucous metaplasia.	MUC5AC MUC5B	1.04e-06	3	21	2	34158522
Pubmed	A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.	BIRC2 BIRC3	1.04e-06	3	21	2	15353805
Pubmed	Assignment of human inhibitor of apoptosis protein (IAP) genes xiap, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluorescence in situ hybridization.	BIRC2 BIRC3	1.04e-06	3	21	2	8938457
Pubmed	GDC-0152 induces apoptosis through down-regulation of IAPs in human leukemia cells and inhibition of PI3K/Akt signaling pathway.	BIRC2 BIRC3	1.04e-06	3	21	2	25273171
Pubmed	Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice.	BIRC2 BIRC3	1.04e-06	3	21	2	23184147
Pubmed	Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells.	MUC5AC MUC5B	1.04e-06	3	21	2	29604272
Pubmed	High-Mobility Group Box 1 Upregulates MUC5AC and MUC5B Expression in Primary Airway Epithelial Cells.	MUC5AC MUC5B	1.04e-06	3	21	2	29286856
Pubmed	Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.	BIRC2 BIRC3	1.04e-06	3	21	2	19464198
Pubmed	Increased Expression of BIRC2, BIRC3, and BIRC5 from the IAP Family in Mesenchymal Stem Cells of the Umbilical Cord Wharton's Jelly (WJSC) in Younger Women Giving Birth Naturally.	BIRC2 BIRC3	1.04e-06	3	21	2	32322338
Pubmed	IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells.	MUC5AC MUC5B	1.04e-06	3	21	2	19596978
Pubmed	Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.	BIRC2 BIRC3	1.04e-06	3	21	2	21447281
Pubmed	Nebulized Menthol Impairs Mucociliary Clearance via TRPM8 and MUC5AC/MUC5B in Primary Airway Epithelial Cells.	MUC5AC MUC5B	1.04e-06	3	21	2	36675209
Pubmed	cIAP1/2 negatively regulate RANKL-induced osteoclastogenesis through the inhibition of NFATc1 expression.	BIRC2 BIRC3	1.04e-06	3	21	2	23126497
Pubmed	PERK-dependent regulation of IAP translation during ER stress.	BIRC2 BIRC3	1.04e-06	3	21	2	19029953
Pubmed	Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium.	MUC5AC MUC5B	1.04e-06	3	21	2	19556605
Pubmed	Future Therapeutic Directions for Smac-Mimetics.	BIRC2 BIRC3	1.04e-06	3	21	2	32053868
Pubmed	Aquaporin 5 expression increases mucin production in lung adenocarcinoma.	MUC5AC MUC5B	1.04e-06	3	21	2	21455588
Pubmed	Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps.	MUC5AC MUC5B	1.04e-06	3	21	2	29802623
Pubmed	Gas1 is induced during and participates in excitotoxic neuronal death.	BIRC2 BIRC3	1.04e-06	3	21	2	11906213
Pubmed	Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue.	MUC5AC MUC5B	1.04e-06	3	21	2	20422702
Pubmed	Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.	BIRC2 BIRC3	1.04e-06	3	21	2	16983704
Pubmed	Inhibitor of apoptosis proteins as novel targets in inflammatory processes.	BIRC2 BIRC3	1.04e-06	3	21	2	21817100
Pubmed	MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.	BIRC2 BIRC3	1.04e-06	3	21	2	19276372
Pubmed	Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells.	BIRC2 BIRC3	1.04e-06	3	21	2	14960576
Pubmed	Mucin gene polymorphisms in otitis media patients.	MUC5AC MUC5B	1.04e-06	3	21	2	19718741
Pubmed	IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases.	BIRC2 BIRC3	2.08e-06	4	21	2	9545235
Pubmed	Catalytic-independent inhibition of cIAP1-mediated RIP1 ubiquitination by EGLN3.	BIRC2 BIRC3	2.08e-06	4	21	2	26612615
Pubmed	Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis.	BIRC2 BIRC3	2.08e-06	4	21	2	22403404
Pubmed	Inhibitor of Apoptosis Proteins (IAPs) Limit RIPK1-Mediated Skin Inflammation.	BIRC2 BIRC3	2.08e-06	4	21	2	28647349
Pubmed	Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.	BIRC2 BIRC3	2.08e-06	4	21	2	34389694
Pubmed	Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein.	BIRC2 BIRC3	2.08e-06	4	21	2	10753917
Pubmed	TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).	BIRC2 BIRC3	2.08e-06	4	21	2	21628460
Pubmed	cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation.	BIRC2 BIRC3	2.08e-06	4	21	2	19223549
Pubmed	cIAP1 Localizes to the nuclear compartment and modulates the cell cycle.	BIRC2 BIRC3	2.08e-06	4	21	2	15665297
Pubmed	Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes.	BIRC2 BIRC3	2.08e-06	4	21	2	8552191
Pubmed	A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation.	BIRC2 BIRC3	2.08e-06	4	21	2	24371121
Pubmed	ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites.	MUC5AC MUC5B	2.08e-06	4	21	2	31582416
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5AC MUC5B	2.08e-06	4	21	2	23807779
Pubmed	CIAP2 inhibits anigen receptor signaling by targeting Bcl10 for degredation.	BIRC2 BIRC3	2.08e-06	4	21	2	16775419
Pubmed	A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes.	BIRC2 BIRC3	2.08e-06	4	21	2	32028675
Pubmed	Shigella hijacks the glomulin-cIAPs-inflammasome axis to promote inflammation.	BIRC2 BIRC3	2.08e-06	4	21	2	29191979
Pubmed	IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells.	BIRC2 BIRC3	2.08e-06	4	21	2	17069460
Pubmed	Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome.	BIRC2 BIRC3	2.08e-06	4	21	2	22195745
Pubmed	An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1.	BIRC2 BIRC3	2.08e-06	4	21	2	22332634
Pubmed	Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo.	BIRC2 BIRC3	2.08e-06	4	21	2	15798218
Cytoband	11q22	BIRC2 BIRC3	1.09e-05	11	21	2	11q22
Cytoband	6p21.3	ABHD16A CYP21A2 BRD2	1.97e-04	250	21	3	6p21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr11q22	BIRC2 BIRC3	1.10e-03	107	21	2	chr11q22
Cytoband	11p15.5	MUC5AC MUC5B	1.33e-03	118	21	2	11p15.5
Cytoband	Ensembl 112 genes in cytogenetic band chr6p21	ABHD16A CYP21A2 BRD2	1.50e-03	503	21	3	chr6p21
Cytoband	Ensembl 112 genes in cytogenetic band chr11p15	MUC5AC MUC5B	2.71e-02	564	21	2	chr11p15
GeneFamily	Ring finger proteins\|Baculoviral IAP repeat containing\|Caspase recruitment domain containing	BIRC2 BIRC3	1.33e-05	8	13	2	419
GeneFamily	CD molecules\|Mucins	MUC5AC MUC5B	9.95e-05	21	13	2	648
GeneFamily	WD repeat domain containing\|Caspase recruitment domain containing\|Apoptosome	BIRC2 BIRC3	2.05e-04	30	13	2	959
GeneFamily	Ring finger proteins	BIRC2 BIRC3 TRIM48	8.89e-04	275	13	3	58
Coexpression	GALI_TP53_TARGETS_APOPTOTIC_UP	BIRC2 BIRC3	1.71e-05	8	21	2	M16490
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 EEF2 CHD7 DNAJC10	1.82e-06	192	21	4	80a71ab3434076803466ccac0df73468889c7dd3
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 EEF2 CHD7 DNAJC10	1.82e-06	192	21	4	75ce635d669ff77d1fd54e10467f21d5e5d67b08
ToppCell	COVID-19_Severe-B_cell\|COVID-19_Severe / disease group, cell group and cell class	BIRC3 CHD7 GALR1	4.90e-05	153	21	3	701a7d92ee7b22277c8462742a530347cc6f061a
ToppCell	normal_Pleural_Fluid-B_lymphocytes-Undetermined\|normal_Pleural_Fluid / Location, Cell class and cell subclass	BIRC3 EEF2 CHD7	5.60e-05	160	21	3	5744cd30709f38e84f7ec8893dc19d7a288b465a
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC ABHD16A MUC5B	6.03e-05	164	21	3	911081739174ec68bc0893c804e4276b206bea7d
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC ABHD16A MUC5B	6.03e-05	164	21	3	c5bfae7e9497185548c243d6f9ebadbcef48ba7f
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC ABHD16A MUC5B	6.03e-05	164	21	3	76b0ac220b7ca22fbea28a507f01f96ae9f53932
ToppCell	PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POR MUC5AC MUC5B	6.14e-05	165	21	3	baff639a7046fb5cacb70f341b6d24cef3519f8e
ToppCell	PND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POR MUC5AC MUC5B	6.14e-05	165	21	3	dd4d36ff8efb89fee1fb4c48d1b8f46902119909
ToppCell	PND14-Epithelial-Epithelial_Airway-Neurosecretory\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POR MUC5AC MUC5B	6.14e-05	165	21	3	6fdce8b23736409a23884ef3918638ffc067a86f
ToppCell	Club-club-2\|World / Class top	POR MUC5B BRD2	6.25e-05	166	21	3	56f11efb6b686b3ee2c34a051f626e3d761b5112
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	6.47e-05	168	21	3	b275e951ff7109e36da22fc17bd4516f9b9432c4
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	6.47e-05	168	21	3	a0dbe2ee697e29b32aa5f8326445e067ff66c154
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	6.47e-05	168	21	3	0757a5af953901a8faed5774ffec4755fc9c0a6e
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B CYP21A2	6.59e-05	169	21	3	1a684471dbda42e1470e5a889648666e14f25982
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B CYP21A2	6.59e-05	169	21	3	db73dae011ff3749b3706e50ab46d03b775dd6bb
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B CYP21A2	6.59e-05	169	21	3	97b7047b87ce0052d8580565c9b44fd2aa6f0d5c
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B GALR1	7.06e-05	173	21	3	e4d9a9a781acc531bc81c3fcee24d637e805c8e1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	POR MUC5AC MUC5B	7.06e-05	173	21	3	3aa1d28d4814798a772808ed29e1dbbdf92abd03
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC5AC FHOD3 MUC5B	7.06e-05	173	21	3	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	POR MUC5AC MUC5B	7.06e-05	173	21	3	e8afef5ae68983eb8d6515b43952636a47e9d3d4
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST3 TINAG BCO1	7.31e-05	175	21	3	65571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NQO2 TINAG CYP21A2	7.43e-05	176	21	3	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	Club_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MUC5AC MUC5B CYP27C1	7.68e-05	178	21	3	be64d4be23fb96a4cdd7980c58880fdfe817747f
ToppCell	droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NQO2 ABHD16A DNAJC10	7.81e-05	179	21	3	af03705a783e77f75c44fdfa793cfdccbf9dd91c
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 CHD7 DNAJC10	8.21e-05	182	21	3	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC5AC FHOD3 MUC5B	8.21e-05	182	21	3	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POR MUC5AC MUC5B	8.34e-05	183	21	3	514b72a1ae55656934839800513385e19bc240e2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NQO2 TINAG CYP21A2	8.34e-05	183	21	3	85446581999cd66b171c4f69b7eb8b0bbbaa8617
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POR MUC5AC MUC5B	8.48e-05	184	21	3	49eccf72725593a8fb4a529e7985a5c413b3ca6a
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POR MUC5AC MUC5B	8.48e-05	184	21	3	41164109d9d7bb1c431220e2e85e08dc5f56856d
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	8.48e-05	184	21	3	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	Control-Epithelial_cells-Tuft-like\|Control / group, cell type (main and fine annotations)	MUC5AC MUC5B EEF2	8.75e-05	186	21	3	9aaab2e81b7ed6a75ded2c3fb1170590c57b74ba
ToppCell	COVID-19_Severe-B_memory\|World / disease group, cell group and cell class	BIRC3 CHD7 DNAJC10	8.89e-05	187	21	3	f29c71f2505bb64f3010ada491d422b87a6f7db3
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	POR MUC5AC CHD7	8.89e-05	187	21	3	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	9.03e-05	188	21	3	5901b276f2379abf486b8285957277e95f08464e
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	N4BP2L2 EEF2 BRD2	9.03e-05	188	21	3	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	MUC5AC FHOD3 MUC5B	9.18e-05	189	21	3	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	9.32e-05	190	21	3	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	9.32e-05	190	21	3	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 EEF2 DNAJC10	9.47e-05	191	21	3	8dda37ebf74b587129795f61541cc511ec97a314
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC ABHD16A MUC5B	9.47e-05	191	21	3	529068029fb461df766135576dd0d8b5980f9bc0
ToppCell	T_cells-Central_memory_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	BIRC3 EEF2 CHD7	9.47e-05	191	21	3	25dd538d6a361bd3367c8a1c0dfc9e7003061af3
ToppCell	healthy_donor-Lymphocytic-B_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	BIRC3 CHD7 DNAJC10	9.62e-05	192	21	3	7d9e5772b6e531b50ed4e4d6304ef11235f27f37
ToppCell	healthy_donor-Lymphocytic-B_cell-\|healthy_donor / Disease condition, Lineage, Cell class and subclass	BIRC3 CHD7 DNAJC10	9.62e-05	192	21	3	975312f9d6cede4d4f5b737e481e5c73accc8c50
ToppCell	Club_cells\|World / lung cells shred on cell class, cell subclass, sample id	MUC5AC MUC5B CYP27C1	9.76e-05	193	21	3	9d3165dc5763a07a7d873f497624d9d6528fa2db
ToppCell	COVID_non-vent-Lymphocytic-B_cell-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	BIRC3 EEF2 CHD7	9.76e-05	193	21	3	91955c3773c9729a96e82f240f06b072367970d9
ToppCell	COVID_non-vent-Lymphocytic-B_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	BIRC3 EEF2 CHD7	9.76e-05	193	21	3	32d139f922cd19adc1cc1e0e9a828115be9945d6
ToppCell	Goblet\|World / shred by cell class for turbinate	POR MUC5AC DNAJC10	9.91e-05	194	21	3	03b62e7cff5e7a6e7bd7d9dda273c74bf9c1f42e
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 CHD7 DNAJC10	9.91e-05	194	21	3	40c7f9bd69a8e843b81972e25a67f591021415dd
ToppCell	Severe-CD4+_T\|World / Disease group and Cell class	BIRC3 EEF2 CHD7	9.91e-05	194	21	3	2ad888f78765ecfb8d1ea978c75c90fa3030509a
ToppCell	CV-Severe-6\|Severe / Virus stimulation, Condition and Cluster	POR BIRC2 BIRC3	9.91e-05	194	21	3	d33be6ed1de907aeea0c2dce09796556b8efdd4e
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 CHD7 DNAJC10	1.01e-04	195	21	3	51e6cfecd66a874673d0b79a295489a358bddfd5
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 N4BP2L2 EEF2	1.01e-04	195	21	3	5001e68df2ad5df9dc93ae235f984ffafea6b521
ToppCell	Epithelial_cells-Club_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	MUC5AC MUC5B CYP27C1	1.01e-04	195	21	3	b758676abfc4e6930b696d270ecc0ea461b87a54
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 N4BP2L2 EEF2	1.01e-04	195	21	3	07035a5972a78b98e4ab2167e3a5000f9f3b0826
ToppCell	Severe-CD4+_T\|Severe / Disease group and Cell class	BIRC3 EEF2 CHD7	1.02e-04	196	21	3	576e0aa2ae146a86201dea21097ffe1c867956e7
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B DNAJC10	1.02e-04	196	21	3	2c3fbfbb08cd327cd97b3fa5a6f83b6d50771fb7
ToppCell	(05)_Secretory\|World / shred by cell type by condition	MUC5AC BIRC3 MUC5B	1.02e-04	196	21	3	8032c25b51ef96aeba28cc52686a2bd45213453d
ToppCell	distal-Epithelial-Goblet\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC5AC MUC5B BCO1	1.04e-04	197	21	3	da1ed7303cc9cb2d205c0e5c49c52544d3540951
ToppCell	distal-3-Epithelial-Goblet\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC5AC MUC5B BCO1	1.04e-04	197	21	3	a00784ccfb1de6a96b91e2a8a2889b69f31a33da
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 N4BP2L2 EEF2	1.04e-04	197	21	3	9373fcd728016b7af1abd7d88c47b7db79eb6a2f
ToppCell	COVID-19_Severe-CD4+_T_naive\|COVID-19_Severe / Disease condition and Cell class	BIRC3 EEF2 CHD7	1.04e-04	197	21	3	ac26672bd2cb3bc9a11206d8da203bafec3931f6
ToppCell	distal-Epithelial-Goblet-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC5AC MUC5B BCO1	1.04e-04	197	21	3	3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 N4BP2L2 EEF2	1.05e-04	198	21	3	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BIRC3 N4BP2L2 EEF2	1.05e-04	198	21	3	239bef79ebaa6e1d8618c670c1050a02362058ee
ToppCell	Control-Epithelial_cells-Cycling_epithelial\|Control / group, cell type (main and fine annotations)	MUC5AC MUC5B EEF2	1.05e-04	198	21	3	b43290d2f8ca45b4a21cb6dbdf1b4384897672e0
ToppCell	distal-Epithelial-Mucous-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC5AC MUC5B CYP21A2	1.07e-04	199	21	3	35fb7bd35e53d8ca189fe8c7744211a5201081f6
ToppCell	T_cells-CCR7+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	BIRC3 EEF2 CHD7	1.07e-04	199	21	3	467820d6abe3024d9d655b9672c2f9cdc1303db3
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BIRC3 CHD7 DNAJC10	1.08e-04	200	21	3	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BIRC3 EEF2 BRD2	1.08e-04	200	21	3	55f19f990fa02664aa02812f6fc65f93d5e7f382
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CHD7 DNAJC10	4.92e-04	70	21	2	37e34ef782b253c43628d5bb2fe5e0294573d0ef
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-6\|TCGA-Cervix / Sample_Type by Project: Shred V9	BIRC2 BIRC3	1.23e-03	111	21	2	45a8e069369fdc7358135bf2229defbee1ac2600
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-double-positive,_alpha-beta_thymocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC5AC MUC5B	1.46e-03	121	21	2	25fa58d8e07dab572b2ba8e23c9d1ad3502dfc56
ToppCell	TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma\|TCGA-Testes / Sample_Type by Project: Shred V9	G6PC3 TRIM48	1.91e-03	139	21	2	6b58d01ce9d9ac23434333f9faf1bb0eef14ba90
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	NDST3 GALR1	2.05e-03	144	21	2	08005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCell	TCGA-Adrenal\|World / Sample_Type by Project: Shred V9	CYP21A2 GALR1	2.08e-03	145	21	2	522ad2bc90b8ec326fcbc7b2250b09566efeeca2
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BIRC2 CYP27C1	2.11e-03	146	21	2	cffa91d76606f74553d81150adbb23b003746316
ToppCell	Club_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	MUC5AC MUC5B	2.14e-03	147	21	2	5a824c89e4d045af465d7333275f8191fb29b041
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MUC5B TINAG	2.14e-03	147	21	2	aba44c7057096483c4293a7ebcf8ccc8baed0231
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	G6PC3 BRD2	2.14e-03	147	21	2	f703cb0330304799d16e457215269c7732c9d5d5
ToppCell	COVID-19_Severe-B_cell\|World / disease group, cell group and cell class	CHD7 GALR1	2.20e-03	149	21	2	9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127
ToppCell	Club_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MUC5AC MUC5B	2.20e-03	149	21	2	81c813588bb5efb7b31141a75d387210dcb76094
ToppCell	facs-Aorta-Heart-3m-Epithelial\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST3 MUC5B	2.25e-03	151	21	2	bee48137d1f5f27a24571a59c835284651d38538
ToppCell	facs-Aorta-Heart-3m-Epithelial-epithelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST3 MUC5B	2.25e-03	151	21	2	0de76acd1b204345dce7f33be2a1ed9fbe9e6da0
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EEF2 GALR1	2.25e-03	151	21	2	3744e4ed87703a97002e001afd16490d525a5128
ToppCell	facs-Aorta-Heart-3m-Epithelial-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST3 MUC5B	2.25e-03	151	21	2	20b9c8fb966c5d62ff909cc4a4616b109b78cdca
ToppCell	P15-Epithelial-epithelial_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MUC5B TINAG	2.28e-03	152	21	2	00d5503d462cfa009fb4cac79ecee11725a18b9a
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FHOD3 MUC5B	2.28e-03	152	21	2	1b2a39ae159e79f1fb18d6d164bd7acab5299fca
ToppCell	frontal_cortex\|World / Per Region, Lineage, Cell class, Cell type, Cell subtype	NQO2 NDST3	2.28e-03	152	21	2	f9c29d4568402ca07a717dbffb3ccc7f35c5fe56
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B CYP21A2	2.31e-03	153	21	2	edf5d026e8e4c685b7c369d70894741bb2cd568e
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B CYP21A2	2.31e-03	153	21	2	3240d4d690335ba22317b1f3d33f9ea069e93838
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B CYP21A2	2.34e-03	154	21	2	ec56b7fb88e39041416c384f371c767f3b4e92fa
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B	2.37e-03	155	21	2	62b59cb32b12bd55b19e98786a866d788fc9e4bf
ToppCell	Goblet\|World / Class top	MUC5B DNAJC10	2.43e-03	157	21	2	b352aa37d662629db6a9c6def9ee6d7c49a9071c
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5AC MUC5B	2.43e-03	157	21	2	c43f2e1ea53b375a7432f17f87cfef3b2261003d
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	BIRC3 GALR1	2.43e-03	157	21	2	7ceae5fe00c91d4feb8c314d3a31f027c03fa56f
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST3 FHOD3	2.46e-03	158	21	2	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NDST3 FHOD3	2.46e-03	158	21	2	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FHOD3 CYP27C1	2.46e-03	158	21	2	d78e7e52657dc094430291fec07e9c298be9e584
Computational	Anti-apoptosis.	BIRC2 BIRC3	2.44e-04	17	15	2	MODULE_537
Drug	T0M	POR BIRC2 BIRC3	1.48e-07	12	21	3	CID000017116
Drug	embelin	G6PC3 BIRC2 BIRC3	2.18e-06	28	21	3	CID000003218
Drug	Akt-I-1 compound	BIRC2 BIRC3	2.43e-06	3	21	2	ctd:C501520
Drug	aclacinomycins	BIRC2 BIRC3	2.43e-06	3	21	2	ctd:C011157
Drug	Capsaicin	NQO2 POR BIRC2 MUC5AC MUC5B EEF2	3.88e-06	488	21	6	ctd:D002211
Drug	gamma-secretase inhibitor I	BIRC2 BIRC3	4.86e-06	4	21	2	CID011754711
Drug	AVPW	BIRC2 BIRC3	8.09e-06	5	21	2	CID009549245
Drug	NSC-725021	BIRC2 BIRC3	1.21e-05	6	21	2	CID000406741
Drug	tephrosin	BIRC2 BIRC3	1.21e-05	6	21	2	ctd:C480848
Drug	kamebakaurin	BIRC2 BIRC3	1.21e-05	6	21	2	ctd:C047382
Drug	Dendroaspis natriuretic peptide	BIRC2 BIRC3	1.21e-05	6	21	2	ctd:C075597
Drug	SN 23862	NQO2 POR	1.70e-05	7	21	2	CID000126690
Drug	Aklavin hydrochloride	BIRC2 BIRC3	1.70e-05	7	21	2	CID000002074
Drug	potassium ferricyanide	G6PC3 NQO2 POR	1.82e-05	56	21	3	CID000026250
Drug	gastrin 17	BIRC2 BIRC3	2.26e-05	8	21	2	ctd:C013550
Drug	delta 5-pregnenediol	POR CYP21A2	2.26e-05	8	21	2	CID000094194
Drug	thiobenzamide S-oxide	G6PC3 POR	2.26e-05	8	21	2	CID000099495
Drug	1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate	BIRC2 BIRC3	2.26e-05	8	21	2	ctd:C477931
Drug	isoalloxazine	NQO2 POR BRD2	3.41e-05	69	21	3	CID005372720
Drug	diethylstilbestrol quinone	NQO2 POR	3.63e-05	10	21	2	CID003034826
Drug	tetronic acid	BIRC2 BIRC3	3.63e-05	10	21	2	CID000521261
Drug	Gold	POR BIRC2 BIRC3 EEF2 DNAJC10	3.80e-05	432	21	5	ctd:D006046
Drug	anthraquinone-2-sulfonate	NQO2 POR	4.43e-05	11	21	2	CID000008551
Drug	ajoene	BIRC2 BIRC3	4.43e-05	11	21	2	ctd:C048980
Drug	SM 164	BIRC2 BIRC3	4.43e-05	11	21	2	ctd:C533467
Drug	5-phenylselenylmethyl-2'-deoxyuridine	BIRC2 BIRC3	4.43e-05	11	21	2	ctd:C558289
Drug	5-methylselenylmethyl-2'-deoxyuridine	BIRC2 BIRC3	4.43e-05	11	21	2	ctd:C558288
Drug	3-methylcholanthrene	G6PC3 NQO2 POR CYP21A2	5.40e-05	231	21	4	CID000001674
Drug	S)-HDAC42	BIRC2 BIRC3	6.28e-05	13	21	2	CID006918801
Drug	cyprodime hydrobromide	MUC5AC BRD2	6.28e-05	13	21	2	CID005748293
Drug	5-hydroxy-2(5H)-furanone	BIRC2 BIRC3	6.28e-05	13	21	2	CID000021076
Drug	Bendamustine Hydrochloride	BIRC2 BIRC3	6.28e-05	13	21	2	ctd:D000069461
Drug	ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate	BIRC2 BIRC3	7.32e-05	14	21	2	ctd:C530049
Drug	dehydroxymethylepoxyquinomicin	BIRC2 BIRC3	8.45e-05	15	21	2	ctd:C464444
Drug	lapachol	NQO2 POR	9.65e-05	16	21	2	CID000003884
Drug	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid	BIRC2 BIRC3	1.09e-04	17	21	2	ctd:C406734
Drug	Flavin-Adenine Dinucleotide	NQO2 POR	1.23e-04	18	21	2	DB03147
Drug	deca-2,4-dienal	BIRC2 BIRC3	1.37e-04	19	21	2	CID000016899
Drug	AC1L235Y	BIRC2 BIRC3	1.37e-04	19	21	2	CID000065390
Drug	menadione	NQO2 POR BIRC2 BIRC3	1.48e-04	300	21	4	CID000004055
Drug	3-(4-methylphenylsulfonyl)-2-propenenitrile	BIRC2 MUC5AC BIRC3	1.48e-04	113	21	3	ctd:C434003
Drug	BP-3,6-quinone	NQO2 POR	1.52e-04	20	21	2	CID000018301
Drug	AC1Q7AUJ	G6PC3 POR CYP21A2	1.64e-04	117	21	3	CID000003303
Drug	BP-1,6-quinone	NQO2 POR	1.85e-04	22	21	2	CID000018300
Drug	17 alpha-hydroxy-20 beta-dihydroprogesterone	POR CYP21A2	1.85e-04	22	21	2	CID000107701
Drug	hydroxyphenylglycine	EEF2 BRD2	1.85e-04	22	21	2	CID000067149
Drug	lonafarnib	BIRC2 BIRC3 EEF2	1.95e-04	124	21	3	CID000148195
Drug	hyperforin	POR EEF2	2.03e-04	23	21	2	ctd:C001654
Drug	hexobarbital	G6PC3 POR CYP21A2	2.09e-04	127	21	3	CID000003608
Drug	AC1L2LVM	BIRC2 BIRC3	2.21e-04	24	21	2	CID000023204
Drug	epicholesterol	G6PC3 POR ABHD16A CYP27C1 CYP21A2	2.35e-04	636	21	5	CID000000304
Drug	danthron	BIRC2 BIRC3	2.40e-04	25	21	2	ctd:C004315
Drug	thiobenzamide	G6PC3 POR	2.60e-04	26	21	2	CID000683563
Drug	lonafarnib	BIRC2 BIRC3	2.60e-04	26	21	2	ctd:C115354
Drug	NSC400385	BIRC2 BIRC3	2.60e-04	26	21	2	CID000259185
Drug	diphthamide	EEF2 BRD2	2.80e-04	27	21	2	CID005460185
Drug	tetra-chloride	G6PC3 POR	3.02e-04	28	21	2	CID000076700
Drug	nivalenol	MUC5AC MUC5B	3.02e-04	28	21	2	ctd:C038405
Drug	CB1954	NQO2 POR	3.24e-04	29	21	2	CID000089105
Drug	quebrachitol	BIRC2 BIRC3	3.24e-04	29	21	2	CID000151108
Drug	1'-acetoxychavicol acetate	BIRC2 BIRC3	3.71e-04	31	21	2	ctd:C047948
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	MUC5AC BIRC3 MUC5B	3.83e-04	156	21	3	1010_UP
Drug	CHAPS detergent	NQO2 POR BCO1	3.98e-04	158	21	3	CID000107670
Drug	4-Aminopyridine	BIRC2 BIRC3	4.20e-04	33	21	2	ctd:D015761
Drug	evodiamine	BIRC2 BIRC3	4.47e-04	34	21	2	ctd:C049639
Drug	dibenzothiophene	NQO2 BCO1	4.73e-04	35	21	2	CID000003023
Drug	riboflavin 5'-phosphate	NQO2 POR BRD2	5.01e-04	171	21	3	CID000000710
Drug	aminopyrine	G6PC3 POR CYP21A2	5.01e-04	171	21	3	CID000006009
Drug	Compound 10	BIRC2 BIRC3	5.29e-04	37	21	2	CID003749170
Drug	Ro 41-5253	MUC5AC BCO1	5.29e-04	37	21	2	CID005312120
Drug	bendamustine	BIRC2 BIRC3	5.29e-04	37	21	2	CID000065628
Drug	AC1L32JY	NQO2 POR	5.29e-04	37	21	2	CID000107685
Drug	K-K-K	NQO2 POR CYP21A2	5.36e-04	175	21	3	CID000003823
Drug	AC1NR9P8	BIRC2 BIRC3	5.58e-04	38	21	2	CID005287445
Drug	taurolidine	BIRC2 BIRC3	5.88e-04	39	21	2	CID000029566
Drug	o-phenylphenol	NQO2 POR	5.88e-04	39	21	2	CID000007017
Drug	quinol	NQO2 POR BIRC3	5.91e-04	181	21	3	CID000000785
Drug	1,2-naphthoquinone	NQO2 POR	6.19e-04	40	21	2	CID000010667
Drug	AC1L1GSB	BIRC2 BIRC3	6.19e-04	40	21	2	CID000003819
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; PC3; HT_HG-U133A	MUC5AC BIRC3 CHD7	6.20e-04	184	21	3	7295_UP
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A	POR MUC5AC MUC5B	6.30e-04	185	21	3	7055_UP
Drug	sulforaphane	NQO2 BIRC2 BIRC3	6.71e-04	189	21	3	CID000005350
Drug	PTBP	BIRC2 BIRC3	6.82e-04	42	21	2	CID000007393
Drug	N,N-dimethylaniline	G6PC3 POR	6.82e-04	42	21	2	CID000000949
Drug	0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A	BIRC3 MUC5B BCO1	7.13e-04	193	21	3	4712_UP
Drug	Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MUC5AC CHD7 BCO1	7.13e-04	193	21	3	3166_UP
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	G6PC3 POR BIRC3	7.45e-04	196	21	3	2936_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HG-U133A	G6PC3 N4BP2L2 DNAJC10	7.45e-04	196	21	3	1921_DN
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	MUC5AC MUC5B BCO1	7.56e-04	197	21	3	2308_UP
Drug	Imipenem [74431-23-5]; Up 200; 13.4uM; PC3; HT_HG-U133A	MUC5AC BIRC3 N4BP2L2	7.68e-04	198	21	3	7294_UP
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; HL60; HG-U133A	POR EEF2 DNAJC10	7.68e-04	198	21	3	1981_UP
Drug	TN-2	BIRC2 BIRC3	7.83e-04	45	21	2	CID006852143
Drug	AC1L1BJZ	POR GALR1	7.83e-04	45	21	2	CID000026634
Drug	17-hydroxypregnenolone	POR CYP21A2	8.18e-04	46	21	2	CID000091451
Drug	chrysoin	BIRC2 BIRC3	8.18e-04	46	21	2	CID005464545
Drug	ethanol	G6PC3 POR MUC5AC EEF2 CYP21A2	8.26e-04	837	21	5	CID000000702
Drug	DEET	POR CYP27C1 CYP21A2	8.37e-04	204	21	3	ctd:D003671
Drug	AC1L1KZZ	BIRC2 BIRC3	8.54e-04	47	21	2	CID000005725
Drug	zerumbone	BIRC2 BIRC3	8.91e-04	48	21	2	ctd:C403304
Drug	AC1NRAJO	BIRC2 BIRC3	8.91e-04	48	21	2	CID005287929
Disease	congenital adrenal hyperplasia (is_implicated_in)	POR CYP21A2	7.22e-06	6	21	2	DOID:0050811 (is_implicated_in)
Disease	Congenital adrenal hyperplasia	POR CYP21A2	1.73e-05	9	21	2	C0001627
Disease	pulmonary fibrosis	MUC5AC MUC5B	2.64e-05	11	21	2	EFO_0009448
Disease	aspartate measurement	NDST3 CYP21A2	1.32e-04	24	21	2	EFO_0010462
Disease	colorectal cancer (is_marker_for)	BIRC2 BIRC3 EEF2	1.83e-04	157	21	3	DOID:9256 (is_marker_for)
Disease	lung non-small cell carcinoma (is_marker_for)	BIRC2 BIRC3 EEF2	2.28e-04	169	21	3	DOID:3908 (is_marker_for)
Disease	urinary albumin to creatinine ratio	POR CHD7 CYP21A2	2.69e-04	179	21	3	EFO_0007778
Disease	COVID-19 symptoms measurement	MUC5AC MUC5B	2.83e-04	35	21	2	EFO_0600019
Disease	metabolite measurement	NQO2 POR CYP21A2 BCO1	5.94e-04	560	21	4	EFO_0004725
Disease	urinary metabolite measurement	NQO2 CYP21A2 TRIM48	6.73e-04	245	21	3	EFO_0005116
Disease	leukemia	BIRC2 BIRC3	7.00e-04	55	21	2	C0023418
Disease	idiopathic pulmonary fibrosis	MUC5AC MUC5B	7.52e-04	57	21	2	EFO_0000768
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5AC MUC5B	8.61e-04	61	21	2	DOID:3587 (is_marker_for)
Disease	cystic fibrosis (is_marker_for)	MUC5AC MUC5B	8.89e-04	62	21	2	DOID:1485 (is_marker_for)
Disease	oral squamous cell carcinoma (is_marker_for)	BIRC2 BIRC3	9.18e-04	63	21	2	DOID:0050866 (is_marker_for)
Disease	cholangiocarcinoma (is_marker_for)	MUC5AC MUC5B	9.47e-04	64	21	2	DOID:4947 (is_marker_for)
Disease	interstitial lung disease	MUC5AC MUC5B	1.04e-03	67	21	2	EFO_0004244
Disease	citrate measurement	POR CYP21A2	1.44e-03	79	21	2	EFO_0010114
Disease	eosinophil percentage of leukocytes	POR MUC5AC CHD7 CYP21A2	1.72e-03	746	21	4	EFO_0007991
Disease	hypertrophic cardiomyopathy	FHOD3 TRIM48	1.94e-03	92	21	2	EFO_0000538
Disease	albuminuria	CHD7 CYP21A2	2.03e-03	94	21	2	EFO_0004285

Protein segments in the cluster

Peptide	Gene	Start	Entry
FIPKPWREFCRSWDG	CYP27C1	281	Q4G0S4
FDFRSWPVDFHWEEP	ABHD16A	151	O95870
DDPWVQHAKWFPRCE	BIRC3	306	Q13489
PFHAEVPADWWDKEA	CHD7	1776	Q9P2D1
PKCEWTEWFDVDFPT	MUC5B	1786	Q9HC84
DCLLGSVDEFWWFPH	NDST3	366	O95803
FITWREQFWPAVCEH	POR	216	P16435
AFKWCERPEWIHVDS	G6PC3	231	Q9BUM1
TVWERPHEFWPDRFL	CYP21A2	396	P08686
HPRCTWTKWFDVDFP	MUC5AC	3521	P98088
DCHPLCAWTKWFDVD	MUC5AC	4626	P98088
WKEEPIPCTAHWHFG	NQO2	216	P16083
FCWEQWPDPRHKKAY	GALR1	186	P47211
LFWNEVRPFDWPCKN	FHOD3	896	Q2V2M9
WDVAEARKIWCFGPD	EEF2	641	P13639
NDKEPWLVDFFAPWC	DNAJC10	466	Q8IXB1
RHCPAEWAAEEHWEK	TRIM48	141	Q8IWZ4
DPWVEHAKWFPRCEF	BIRC2	321	Q13490
WKHQFAWPFRQPVDA	BRD2	91	P25440
LKWREDDCWPAEPLF	BCO1	446	Q9HAY6
FCREEKEWPPHTQPW	TINAG	101	Q9UJW2
FHEPETWWKFDPEEL	N4BP2L2	501	Q92802